Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018

Widespread Generic Erosion of Atypical Antipsychotics Will Cause the Bipolar Disorder Drug Market to Decline By More Than $1 Billion Through 2018

Earthtimes - 58 minutes ago
Beginning in 2011, Key Agents from AstraZeneca, Eli Lilly, Pfizer and Bristol-Myers Squibb/Otsuka Will Lose Patent Exclusivity, According to a New Report from Decision Resources WALTHAM, Mass ...